glp 1 deficiency symptoms GLP-1 weight loss drugs leave users low on key nutrients, study finds GLP-1 RAs and Skin Health:
Description
But Eli Lilly is right on its heels
The FDA approved once-daily oral semaglutide (Wegovy) at 25 mg on 22 December 2025, making it the first oral GLP-1 approved specifically for chronic weight management in the US
Head-to-head clinical studies have indicated that GLP-1-RAs outperform conventional antidiabetic medicines in terms of glycemic management and weight reduction
[DOI] [PubMed] [Google Scholar] 71.Kamrul-Hasan ABM, Dutta D, Nagendra L, Bhattacharya S, Singla R, Kalra S
Most users inject into their abdomen or thigh once per week
Zhang X, Cao C, Zheng F, Liu C, Tian X
